
    
      Patients will receive daily IV infusions of ORGN001 (formerly ALXN1101) starting on Day 1.
      After a prescribed period, dosing will increase monthly based on defined patient safety
      measures. After Month 6, patients will continue daily dosing at their last tolerated dose.
    
  